The board of directors of the Racing Medication and Testing Consortium (RMTC) voted to approve several important recommendations from its Scientific Advisory Committee (SAC) and Horseracing Testing Laboratories Committee (HTLC) at its February 23 meeting at Gulfstream Park. The Board also received an encouraging report on the significant nationwide adoption progress of the National Uniform Medication Program – highlighted by the update that states which have implemented the Controlled Therapeutic Substances (CTS) list now represent more than 90% of the U.S. handle.
RMTC board members unanimously approved recommendations from the SAC for revised thresholds based on recently completed research for three medications currently among those on the CTS list: xylazine and detomidine (two sedative/analgesic medications) and omeprazole (an anti-ulcer medication). Research for these substances was performed at the UC Davis Maddy Lab, Kentucky Equine Research, and the University of Florida. The thresholds and withdrawal guidance for these substances can be found on the CTS list page of the RMTC website.
“The CTS list is a living document, as evidenced by the addition of a number of medications since it was first enacted,” stated RMTC Executive Director Dr. Dionne Benson. “In this instance, the RMTC and its stakeholders, through the SAC process, revised three historic regulatory thresholds by funding and executing scientific research to ensure horsemen had the best information available to make decisions.”
In addition, RMTC board members voted unanimously to recommend to the Association of Racing Commissioners International (RCI) an expanded and more comprehensive out-of-competition testing rule for horse racing. The recommended model rule addresses sampling procedures and defines what substances are prohibited in a Prohibited Substance List. The Prohibited Substance List is modeled on the WADA Prohibited Substances List –taking into account substances unique to horses' health under specified conditions.
“The proposed model rule including the Prohibited Substance List will provide horse racing an out-of-competition program that is second to none in professional sports,” stated Dr. Benson. “By enacting this rule, we go beyond protecting against just blood doping agents to proactively protecting the health and welfare of the race horse everyday – not just on race day.”
The RMTC will present the revised threshold recommendations, out-of competition model rule proposal and Prohibited Substance List to the RCI and will advocate for their inclusion in the RCI model rules.
Chair Alex Waldrop updated the Board on significant progress toward full adoption of the National Uniform Medication Program. According to Waldrop, 1) the Controlled Therapeutic Substances list has now been adopted in 18 states representing more than 90% of total handle, 2) third-party veterinarian administration of furosemide has been adopted in 17 states representing 65% of total handle, 3) the Multiple Medication Violations penalty system has been adopted in 12 states representing 35% of total handle, and 4) 28 states representing more than 75% of total handle are now receiving testing services from RMTC-accredited and soon-to-be accredited laboratories.
“We expect to see at least half the racing states fully adopt the National Uniform Medication Program by the end of the year,” said Waldrop. “We will get to a point soon where non-compliant states will be faced with the choice of either joining the Program or risk being ostracized by racing fans and participants alike.”
In addition, the Board:
- Approved screening limit recommendations for various environmental contaminants to match environmental residue screening limits used in international horse racing;
- Granted Full Accreditation status to the Texas A&M Veterinary Medical Diagnostic Laboratory and, Interim Accreditation status to the New York Drug Testing and Research Laboratory – the eight laboratory to receive RMTC Accreditation; and
- Approved a split sample submission program for regulators and laboratories to simplify and improve communication in the split sample process.
The RMTC consists of 23 racing industry stakeholders and organizations that represent Thoroughbred, Standardbred, American Quarter Horse and Arabian racing. The organization works to develop and promote uniform rules, policies and testing standards at the national level; coordinate research and educational programs that seek to ensure the integrity of racing and the health and welfare of racehorses and participants; and protect the interests of the racing public.
For additional information, visit the RMTC website at rmtcnet.com or contact Hallie Lewis, RMTC communications and development consultant, at (859) 224-2848.
New to the Paulick Report? Click here to sign up for our daily email newsletter to keep up on this and other stories happening in the Thoroughbred industry.
Copyright © 2019 Paulick Report.